00294nas a2200073   4500000000100000008004100001100001100042245016700053       2020                            d1 aB Neal00aThe effects of combination canagliflozin and glucagon-like peptide-1 receptor agonist therapy on intermediate markers of cardiovascular risk in the CANVAS program